COL1A1 peptides have been previously described to be associated with fibrosis‐related diseases, including heart failure, CKD and liver diseases, indicating that the degradation of the COL1 molecule is altered in fibrosis [9, 27, 28]. The gene discussed is COL1A1; the disease is liver disorder.